SEARCH

SEARCH BY CITATION

References

  • 1.
    Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220228.
  • 2.
    Elliott P, Mckenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:18811891.
  • 3.
    Usui M, Inoue H, Susuki J, et al. Relationship between distribution of hypertrophy and electrocardiographic changes in hypertrophic cardiomyopathy. Am Heart J. 1993;126:177183.
  • 4.
    Alfonso F, Nihoyannopoulos P, Stewart J, et al. Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990;15:965971.
  • 5.
    Lemery R, Kleinebenne A, Nihoyannopoulos P, et al. Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol. 1990;16:368374.
  • 6.
    Yamaguchi H, Ishimura T, Nishiyama S, et al. Hypertrophic non-obstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979;44:401412.
  • 7.
    Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:16991708.
  • 8.
    Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855861.
  • 9.
    Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology. 2004;232:568653.
  • 10.
    Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol. 2007;189:13351343.
  • 11.
    Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol. 2007;189:13441352.
  • 12.
    Kim RJ, Judd RM. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41:15681572.
  • 13.
    Maron BJ. Hypertrophic cardiomyopathy. A systemic review. JAMA. 2002;287:13081320.
  • 14.
    Maron BJ, Mckenna WJ, Danielson GK, et al; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003;24:19651991.
  • 15.
    Dumont CA, Monserrat L, Soler R, et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J. 2006;27:17251731.
  • 16.
    Maron BJ, Wolfson JK, Ciro E, et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol. 1983;51:189194.
  • 17.
    Moon J, Fisher N, Mckenna WJ, et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart. 2004;90:645649.
  • 18.
    Yamada M, Teraoka K, Kawade M, et al. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Int J Cardiovasc Imaging. 2009;25:131138.
  • 19.
    Penas M, Fuster M, Fabregas R, et al. Familial apical hypertrophic cardiomyopathy. Am J Cardiol. 1988;62:821822.
  • 20.
    Matusbara K, Nakamura T, Kuribayashi T, et al. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;42:288295.
  • 21.
    Koga Y, Yamada A, Hiyamuta K, et al. Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J Cardiovasc Electrophysiol. 2004;15:14021408.
  • 22.
    Choudhury L, Mahrholdt H, Wagner A. Myocardial scarring in asymptomatic or mildly symptomatic patient s with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:21562164.
  • 23.
    Moon JC, Mckenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:15611567.
  • 24.
    Moon JC, Reed E, Sheppard MN. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am Coll Cardiol. 2004;43:22602264.
  • 25.
    Satoh H, Matoh F, Shiraki K, et al. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy. J Card Fail. 2009;15:419427.
  • 26.
    Bongioanni S, Spirito P, Masi AS, et al. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features. Circ Cardiovasc Imaging. 2009;2:349350.